Guilin Sanjin Pharmaceutical Statistics

Total Valuation

Guilin Sanjin Pharmaceutical has a market cap or net worth of CNY 7.87 billion. The enterprise value is 6.96 billion.

Market Cap	7.87B
Enterprise Value	6.96B

Important Dates

The next estimated earnings date is Tuesday, October 29, 2024.

Earnings Date	Oct 29, 2024
Ex-Dividend Date	May 29, 2024

Share Statistics

Guilin Sanjin Pharmaceutical has 587.57 million shares outstanding. The number of shares has decreased by -1.07% in one year.

Shares Outstanding	587.57M
Shares Change (YoY)	-1.07%
Shares Change (QoQ)	+0.61%
Owned by Insiders (%)	15.76%
Owned by Institutions (%)	3.35%
Float	124.15M

Valuation Ratios

The trailing PE ratio is 22.98.

PE Ratio	22.98
Forward PE	n/a
PS Ratio	3.85
PB Ratio	2.70
P/FCF Ratio	15.75
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.00, with an EV/FCF ratio of 13.94.

EV / Earnings	20.31
EV / Sales	3.40
EV / EBITDA	14.00
EV / EBIT	17.68
EV / FCF	13.94

Financial Position

The company has a current ratio of 3.31, with a Debt / Equity ratio of 16.60.

Current Ratio	3.31
Quick Ratio	2.75
Debt / Equity	16.60
Debt / EBITDA	0.98
Debt / FCF	0.97
Interest Coverage	72.14

Financial Efficiency

Return on equity (ROE) is 11.62% and return on invested capital (ROIC) is 7.14%.

Return on Equity (ROE)	11.62%
Return on Assets (ROA)	6.49%
Return on Capital (ROIC)	7.14%
Revenue Per Employee	782,354
Profits Per Employee	131,063
Employee Count	2,615
Asset Turnover	0.54
Inventory Turnover	2.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.64% in the last 52 weeks. The beta is 0.38, so Guilin Sanjin Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-14.64%
50-Day Moving Average	13.05
200-Day Moving Average	13.75
Relative Strength Index (RSI)	53.69
Average Volume (20 Days)	3,194,987

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Guilin Sanjin Pharmaceutical had revenue of CNY 2.05 billion and earned 342.73 million in profits. Earnings per share was 0.58.

Revenue	2.05B
Gross Profit	1.49B
Operating Income	393.77M
Pretax Income	439.46M
Net Income	342.73M
EBITDA	486.12M
EBIT	393.77M
Earnings Per Share (EPS)	0.58

Full Income Statement

Balance Sheet

The company has 1.39 billion in cash and 486.72 million in debt, giving a net cash position of 906.44 million or 1.54 per share.

Cash & Cash Equivalents	1.39B
Total Debt	486.72M
Net Cash	906.44M
Net Cash Per Share	1.54
Equity (Book Value)	2.93B
Book Value Per Share	4.95
Working Capital	1.49B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 562.82 million and capital expenditures -63.35 million, giving a free cash flow of 499.47 million.

Operating Cash Flow	562.82M
Capital Expenditures	-63.35M
Free Cash Flow	499.47M
FCF Per Share	0.85

Full Cash Flow Statement

Margins

Gross margin is 72.95%, with operating and profit margins of 19.25% and 16.75%.

Gross Margin	72.95%
Operating Margin	19.25%
Pretax Margin	21.48%
Profit Margin	16.75%
EBITDA Margin	23.76%
EBIT Margin	19.25%
FCF Margin	24.41%

Dividends & Yields

This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 4.48%.

Dividend Per Share	0.60
Dividend Yield	4.48%
Dividend Growth (YoY)	-25.00%
Years of Dividend Growth	n/a
Payout Ratio	107.72%
Buyback Yield	1.07%
Shareholder Yield	5.55%
Earnings Yield	4.35%
FCF Yield	6.35%

Dividend Details

Stock Splits

The last stock split was on April 21, 2011. It was a forward split with a ratio of 1.3.

Last Split Date	Apr 21, 2011
Split Type	Forward
Split Ratio	1.3